UBS Group’s MEDIVATION, INC. MDVN Stock Holding History

UBS Group’s Portfolio MDVN Stock Details MDVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-85,000	Closed	-$3.91M	–	8431
2016 Q1	$3.91M	Buy	85,000 +84,000	+8,400%	+$3.05M	﹤0.01%	2081
2015 Q4	$48K	Hold	1,000	–	–	﹤0.01%	5872
2015 Q3	$43K	Hold	1,000	–	–	﹤0.01%	5985
2015 Q2	$57K	Sell	1,000 -1,000	-50%	-$61.6K	﹤0.01%	5905
2015 Q1	$129K	Sell	2,000 -1,400	-41%	-$80.2K	﹤0.01%	5227
2014 Q4	$169K	Buy	+3,400	New	+$177K	﹤0.01%	5203

Other funds holding MDVN

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Analytic Investors Los Angeles, California $8.93B AUM 13.54% 1-Year Est. Return

Harvest Management New York $206M AUM 95.44% 1-Year Est. Return

LIM

Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Marcus Capital Northbrook, Illinois $34.3M AUM 30.44% 1-Year Est. Return

UBS Group's MDVN Position: Q3 2016 in Review

UBS Group sold out of MEDIVATION, INC. (MDVN) in Q3 2016, closing a stake of 467,641 shares — an estimated $28.2M sold.

UBS Group first reported a position in MDVN in Q4 2014 and held it in 7 quarters. The position peaked at $41.1M in Q1 2015. 53 funds tracked by Wall St. Rank hold MDVN as of Q3 2016.

UBS Group reported no remaining MEDIVATION, INC. position as of Q3 2016 after selling out during the quarter.
UBS Group sold 467,641 MEDIVATION, INC. shares in Q3 2016, an estimated $28.2M.
UBS Group first reported a position in MEDIVATION, INC. in Q4 2014 and held it in 7 quarters.
UBS Group's MEDIVATION, INC. position peaked at $41.1M in Q1 2015.
53 funds tracked by Wall St. Rank held MEDIVATION, INC. as of Q3 2016.

Based on UBS Group's 13F filing for Q3 2016, filed 14 Nov 2016.